Search Results - Allen Cohn
- Showing 1 - 1 results of 1
-
1
Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer by David Fogelman, Antonio Cubillo, Pilar García‐Alfonso, María Luisa Limón Mirón, John Nemunaitis, Daniel Flora, Christophe Borg, Laurent Mineur, Jose M. Vieitez, Allen Cohn, Gene Saylors, Albert Assad, Julie Switzky, Li Zhou, Johanna Bendell
Published in Cancer Medicine (2018-11-01)Get full text
Article
